5-Fluoro-2-(4-methyl-piperazin-1-yl)-phenylamine, 1g

1-((4-Nitrophenyl)sulfonyl)-1H-1,2,4-triazole, 1g

Ethyl 3-(trimethylsilyl) propiolate, 98%, 1g

4-(4-Chloro-6-methoxy-9h-pyrimido[4,5-b]indol-7-yl)-3,5-dimethyl-isoxazole, 98%, 500mg

3-Sulfamoyl-benzoic acid, 95.0%, 250mg

Hydridotetrakis(triphenylphosphine)rhodium(I), 98%, 1g

2,6-Dimethylquinolin-4-amine hydrochloride, 100mg

Télescope central pour le phasage pour les modèles bScope IOS (objectifs corrigés à l'infini)

6-Bromo-8-methyl-[1,2,4]triazolo[1,5-a]pyridine, 97%, 5g

5-Bromo-2,4-dimethylaniline, 95.0%, 5g

2,6-Dioxohexahydropyrimidine-4-carboxylic acid, 95+%, 1g

2,2'-Dimethylbiphenyl>95.0%(GC)1g

N-[4-[5-(1,3-Benzodioxol-5-yl)-3-methoxy-1H-1,2,4-triazol-1-yl]phenyl]-2-(phenylthio)acetamide, 98%, 25mg